| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |